RPTX logo

Repare Therapeutics (RPTX) Company Overview

Profile

Full Name:

Repare Therapeutics Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

June 19, 2020

Indexes:

Not included

Description:

Repare Therapeutics is a biotechnology company focused on developing innovative cancer therapies. They use a unique approach called synthetic lethality to target specific genetic weaknesses in tumors, aiming to create personalized treatments that improve patient outcomes in various types of cancer.

Key Details

Price

$1.15

Annual Revenue

$51.13 M(-61.21% YoY)

Annual EPS

-$2.23(-223.19% YoY)

Annual ROE

-38.16%

Beta

1.52

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 13, 24 Stifel
Buy
Dec 13, 24 LifeSci Capital
Market Perform
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Sep 23, 24 HC Wainwright & Co.
Buy
Sep 4, 24 HC Wainwright & Co.
Buy
Jun 5, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy
Mar 8, 24 HC Wainwright & Co.
Buy
Feb 21, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Repare Therapeutics?
  • Does Repare Therapeutics pay dividends?
  • What sector is Repare Therapeutics in?
  • What industry is Repare Therapeutics in?
  • What country is Repare Therapeutics based in?
  • When did Repare Therapeutics go public?
  • Is Repare Therapeutics in the S&P 500?
  • Is Repare Therapeutics in the NASDAQ 100?
  • Is Repare Therapeutics in the Dow Jones?
  • When was Repare Therapeutics's last earnings report?
  • When does Repare Therapeutics report earnings?
  • Should I buy Repare Therapeutics stock now?

What is the ticker symbol for Repare Therapeutics?

The ticker symbol for Repare Therapeutics is NASDAQ:RPTX

Does Repare Therapeutics pay dividends?

No, Repare Therapeutics does not pay dividends

What sector is Repare Therapeutics in?

Repare Therapeutics is in the Healthcare sector

What industry is Repare Therapeutics in?

Repare Therapeutics is in the Biotechnology industry

What country is Repare Therapeutics based in?

Repare Therapeutics is headquartered in Canada

When did Repare Therapeutics go public?

Repare Therapeutics's initial public offering (IPO) was on June 19, 2020

Is Repare Therapeutics in the S&P 500?

No, Repare Therapeutics is not included in the S&P 500 index

Is Repare Therapeutics in the NASDAQ 100?

No, Repare Therapeutics is not included in the NASDAQ 100 index

Is Repare Therapeutics in the Dow Jones?

No, Repare Therapeutics is not included in the Dow Jones index

When was Repare Therapeutics's last earnings report?

Repare Therapeutics's most recent earnings report was on Nov 7, 2024

When does Repare Therapeutics report earnings?

The next expected earnings date for Repare Therapeutics is May 7, 2025

Should I buy Repare Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions